LeonaBio(LONA)
$3.88-0.14 (-3.48%)
LONA
LeonaBio financials statements
$3.88
At close:-0.14 (-3.48%)
Want to see LONA full AI Analyst Report?
LeonaBio (LONA) Ratios
579 Followers
LeonaBio Ratios
LONA's free cash flow for Q2 2026 was $-16.96M. For the 2026 fiscal year, LONA's free cash flow was increased by $0.00 and operating cash flow was $-16.96M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.88 | 4.18 | 5.37 | 9.68 | 28.07 |
| Quick Ratio | 1.88 | 4.18 | 5.37 | 9.74 | 28.07 |
| Cash Ratio | 1.46 | 3.69 | 3.14 | 4.48 | 11.90 |
| Solvency Ratio | -1.63 | -6.89 | -3.88 | -4.12 | -4.98 |
| Operating Cash Flow Ratio | -0.96 | -7.40 | -3.49 | -3.38 | -4.64 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 25.10M | $ 40.90M | $ 124.67M | $ 184.52M | $ 249.88M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 |
| Debt-to-Capital Ratio | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 3.32 | 1.31 | 1.23 | 1.10 | 1.03 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | -3.62 | -18123.67 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | -4.28 | -21340.67 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.19 | 0.32 | 0.42 | 6.95 | 0.52 |
| Net Debt to EBITDA | 2.06 | 0.49 | 0.71 | 1.07 | 2.00 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 103.27% | 96.07% | 93.79% | 91.95% | 85.68% |
| Return on Assets (ROA) | -114.60% | -164.92% | -73.43% | -37.05% | -16.52% |
| Return on Equity (ROE) | -380.03% | -216.19% | -90.39% | -40.67% | -17.08% |
| Return on Capital Employed (ROCE) | -229.05% | -221.06% | -95.48% | -43.94% | -19.84% |
| Return on Invested Capital (ROIC) | -226.69% | -219.08% | -95.21% | -43.88% | -19.82% |
| Return on Tangible Assets | -114.60% | -164.92% | -73.43% | -37.05% | -16.52% |
| Earnings Yield | -326.28% | -429.16% | -127.37% | -79.96% | -11.40% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 14.84 | 0.00 | 0.00 | 0.00 | 0.84 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -24.59 | 0.00 | 0.00 | 0.00 | -432.06 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 24.59 | 0.00 | 0.00 | 0.00 | 432.06 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -10.69 | -25.25 | -26.50 | -19.21 | -11.67 |
| Free Cash Flow Per Share | -10.69 | -25.26 | -26.58 | -19.51 | -12.10 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -2944.55 | -331.42 | -63.51 | -27.40 |
| Capital Expenditure Coverage Ratio | 0.00 | -2944.55 | -331.42 | -63.51 | -27.40 |
| Operating Cash Flow Coverage Ratio | -56.95 | -79.84 | -63.57 | -37.92 | -22.45 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -141.28% | -430.32% | -109.38% | -61.54% | -9.29% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.31 | -0.23 | -0.79 | -1.25 | -8.77 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 1.16 | 0.50 | 0.71 | 0.51 | 1.50 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.71 | -0.23 | -0.91 | -1.62 | -10.77 |
| Price-to-Operating Cash Flow Ratio | -0.71 | -0.23 | -0.92 | -1.65 | -11.16 |
| Price-to-Earnings Growth (PEG) Ratio | 0.15 | 0.01 | -0.04 | -0.02 | -0.06 |
| Enterprise Value Multiple | 1.09 | 0.26 | -0.03 | -0.29 | -6.85 |
| Enterprise Value | -36.11M | -24.63M | 3.39M | 25.56M | 372.47M |
| EV to EBITDA | 1.09 | 0.26 | -0.03 | -0.29 | -6.85 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | 0.79 | 0.25 | -0.03 | -0.35 | -8.34 |
| EV to Operating Cash Flow | 0.79 | 0.25 | -0.03 | -0.35 | -8.64 |
| Tangible Book Value Per Share | 6.50 | 11.65 | 34.24 | 62.32 | 86.96 |
| Shareholders’ Equity Per Share | 6.50 | 11.65 | 34.24 | 62.32 | 86.96 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -24.70 | -25.19 | -30.95 | -25.35 | -14.86 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 3.09 | 1.00 | 0.93 | 1.08 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.43 | 1.00 | 0.86 | 0.76 | 0.79 |
Currency in USD
